Bank of Montreal’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Bank of Montreal’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-176,274	Closed	-$1.78M	–	4440
2022 Q4	$1.78M	Buy	+176,274	New	+$1.76M	﹤0.01%	1840

Bank of Montreal's EBACU Position: Q1 2023 in Review

Bank of Montreal sold out of European Biotech Acquisition Corp. Units (EBACU) in Q1 2023, closing a stake of 176,274 shares — an estimated $1.78M sold.

Bank of Montreal first reported a position in EBACU in Q4 2022 and held it in 1 quarter. The position peaked at $1.78M in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACU as of Q1 2023.

Bank of Montreal reported no remaining European Biotech Acquisition Corp. Units position as of Q1 2023 after selling out during the quarter.
Bank of Montreal sold 176,274 European Biotech Acquisition Corp. Units shares in Q1 2023, an estimated $1.78M.
Bank of Montreal first reported a position in European Biotech Acquisition Corp. Units in Q4 2022 and held it in 1 quarter.
Bank of Montreal's European Biotech Acquisition Corp. Units position peaked at $1.78M in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.